| HOME >> BIOLOGY >> TECHNOLOGY |
Cash used in operating
activities $(2,129) $(2,257) $(4,551) $(5,365)
-------------------------------------------------------------------------
Issuance of convertible
royalty participation units - (5) - 7,732
Proceeds on exercise of
stock options - 9 - 10
Proceeds on exercise of
warrants - 138 36 155
Repayment of capital lease
obligation - - - (5)
-------------------------------------------------------------------------
Cash provided by financing
activities - $142 $36 $7,892
-------------------------------------------------------------------------
Funds from (purchases of)
short-term investments 748 (1,447) 7,628 (2,811)
Proceeds on disposal of
equipment - - 12 -
Purchases of equipment (109) (99) (184) (171)
-------------------------------------------------------------------------
Cash provided by (used in)
investing activities $639 $(1,546) $7,456 $(2,982)
-------------------------------------------------------------------------
(Decrease) increase in
cash and cash equivalents $(1,490) $(3,661) $2,941 $(455)
Cash and cash equivalents,
beginning of period 7,376 8,949 2,945 5,743
-------------------------------------------------------------------------
Cash and cash equivalents,
end of period $5,886 $5,288 $5,886 $5,288
-------------------------------------------------------------------------
Ab
'/>"/>
| SOURCE MIGENIX Inc. Copyright©2007 PR Newswire. All rights reserved |